In this training, we’ll introduce how you can analyze and interpret your phosphoproteomics data in QIAGEN IPA. Using an example...

Some human studies may be unfeasible or unethical, making cross-species research critical for drug discovery and biomarker validation. Cross-species research...

Environmental contamination of perfluoroalkyl and polyfluoroalkyl substances (PFAS) is of significant concern due to a wide range of adverse health...

QIAGEN Ingenuity Pathway Analysis (IPA) represents a robust resource to aid in the process of writing grants publications. Driven by...

Join us for a 120-minute training session for new users of QIAGEN IPA. Users will learn how to: • Upload...

In this 90-minute training, you'll learn how to perform drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity...

Take your QIAGEN Ingenuity Pathway Analysis (IPA) analyses to the next level by comparing them to your own analyses (different...

Genome-wide association studies (GWAS) provide insights into the genetic architecture of disease by identifying susceptibility loci for the disease within...

Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the...

Single-cell RNA-sequencing (scRNA-seq) is widely used to study tissue heterogeneity, identify novel cell types, study pathogenic mechanisms, develop targeted therapies...